SOURCE: BioMedReports

BioMedReports

December 23, 2010 08:26 ET

Advanced Cell Technology's Chief Medical Officer Featured on National Radio Show About Biotech Breakthroughs

LOS ANGELES, CA--(Marketwire - December 23, 2010) - Dr. Robert Lanza, the Chief Scientific Officer of Advanced Cell Technology (OTCBB: ACTC) was featured and interviewed as "one of the leading scientists making breakthroughs in his field" on Explorations in Science with best-selling author and television personality, Dr. Michio Kaku.

The hour long radio program on science and technology is broadcast each week on WBAI New York City (99.5 FM), and re-aired on stations across the country. The segment focused attention to the future of biotech and included a discussion about Lanza's background including his experiments in the field of animal cloning as well as a brief discourse about his research involving myoblast stem cell therapies.

For only the second time in history, the Food and Drug Administration approved the human trial of a therapy developed from embryonic stem cells when Lanza and the team at Advanced Cell Technology secured approval for human trials of their retinal pigment epithelial cells to treat Stargardt's Macular Dystrophy.

Robert Lanza, M.D. is considered one of the leading scientists in the world. He serves as Advanced Cell Technology's Chief Scientific Officer, and Adjunct Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine. He has hundreds of publications and inventions, and over two dozen scientific books, among them: "Principles of Tissue Engineering," which is recognized as the definitive reference in the field. Others include "One World: The Health & Survival of the Human Species in the 21st Century" (Foreword by former President and Nobel laureate Jimmy Carter), and the "Handbook of Stem Cells" and "Essentials of Stem Cell Biology," which are considered the definitive references in stem cell research.

He is a former Fulbright Scholar, and studied as a student in the laboratory of Richard Hynes (MIT), Jonas Salk (The Salk Institute), and Nobel laureates Gerald Edelman (Rockefeller University) and Rodney Porter (Oxford University). He also worked closely (and coauthored a series of papers) with the late Harvard psychologist B.F. Skinner and heart transplant pioneer Christiaan Barnard. Dr. Lanza received his B.A. and M.D. Degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar.

Dr. Michio Kaku is a theoretical physicist, best-selling author, and popularizer of science. He's the co-founder of string field theory (a branch of string theory), and continues Einstein's search to unite the four fundamental forces of nature into one unified theory. He is a NY Times Bestseller List author and has appeared on television (Discovery, BBC, ABC, Science Channel, and CNN to name a few), written for popular science publications like Discover, Wired, and New Scientist, been featured in documentaries like Me & Isaac Newton, and hosted many of his own including BBC's recent series on Time.

Investors interested in hearing a full recording of program may do so at:

http://biomedreports.com/2010122361754/advanced-cell-technologys-dr-robert-lanza-on-on-explorations-in-science.html

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can also access that information at:

http://biomedreports.com/fda-calendar/fda-calendar.html

News developments and live healthcare sector updates are available constantly via twitter at: http://twitter.com/BioMedReports

About BioMedReports.com

BioMedReports.com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets.

Contact Information

  • Media Contacts Only:
    Mary Davila
    Assistant Editor
    BioMedReports.com
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556